[1] 王新, 李春阳, 苏立平, 等. 动脉粥样硬化发病机制及治疗的研究进展[J]. 实用心脑肺血管病杂志, 2017, 25(2):1-4. doi:  10.3969/j.issn.1008-5971.2017.02.001
[2] 杜文婷, 王臻楠, 顾耘. 动脉粥样硬化的中西医认识概况[J]. 中西医结合心脑血管病杂志, 2016, 14(22):2634-2637. doi:  10.3969/j.issn.1672-1349.2016.22.014
[3] 谢彬, 袁星, 徐希科, 等. 中药复方抗动脉粥样硬化作用机制的研究进展[J]. 药学实践杂志, 2021, 39(4):295-298,304.
[4] 边晶, 张洪义. 苏合香丸古今应用初探[J]. 中医药临床杂志, 2016, 28(6):875-878. doi:  10.16448/j.cjtcm.2016.0310
[5] 国家药典委员会. 中华人民共和国药典（一部）: 2020年版[S]. 北京: 中国医药科技出版社, 2020.
[6]

LU L, SUN X D, CHEN C, et al. Shexiang Baoxin pill, derived from the traditional Chinese medicine, provides protective roles against cardiovascular diseases[J]. Front Pharmacol,2018,9:1161. doi:  10.3389/fphar.2018.01161
[7] 冀元元, 李纲, 李玉东, 等. 麝香保心丸对冠心病患者颈总动脉粥样硬化斑块及炎症因子的影响[J]. 中国老年学杂志, 2015, 35(21):6077-6079. doi:  10.3969/j.issn.1005-9202.2015.21.032
[8] 陶彦谷, 李进营, 韦燕妮, 等. 麝香保心丸防治动脉粥样硬化的实验研究[J]. 中药新药与临床药理, 2015, 26(4):508-511.
[9]

LU L, QIN Y T, ZHANG X X, et al. Shexiang Baoxin pill alleviates the atherosclerotic lesions in mice via improving inflammation response and inhibiting lipid accumulation in the arterial wall[J]. Mediators Inflamm,2019,2019:6710759.
[10]

LUO T T, LU Y, YAN S K, et al. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective[J]. Chin J Integr Med,2020,26(1):72-80. doi:  10.1007/s11655-019-3064-0
[11]

RU J L, LI P, WANG J N, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13. doi:  10.1186/1758-2946-6-13
[12]

XU H Y, ZHANG Y Q, LIU Z M, et al. ETCM: an encyclopaedia of traditional Chinese medicine[J]. Nucleic Acids Res,2019,47(D1):D976-D982. doi:  10.1093/nar/gky987
[13]

LIU Z Y, GUO F F, WANG Y, et al. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine[J]. Sci Rep,2016,6:21146. doi:  10.1038/srep21146
[14]

GUO M F, DAI Y J, GAO J R, et al. Uncovering the mechanism of Astragalus membranaceus in the treatment of diabetic nephropathy based on network pharmacology[J]. J Diabetes Res,2020,2020:5947304.
[15]

REBHAN M, CHALIFA-CASPI V, PRILUSKY J, et al. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support[J]. Bioinformatics,1998,14(8):656-664. doi:  10.1093/bioinformatics/14.8.656
[16]

AMBERGER J S, BOCCHINI C A, SCHIETTECATTE F, et al. OMIM. org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders[J]. Nucleic Acids Res, 2015, 43(Database issue): D789-D798.
[17]

PIÑERO J, RAMÍREZ-ANGUITA J M, SAÜCH-PITARCH J, et al. The DisGeNET knowledge platform for disease genomics: 2019 update[J]. Nucleic Acids Res,2019:845-855.
[18]

ZHOU Y Y, ZHOU B, PACHE L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nat Commun,2019,10(1):1523. doi:  10.1038/s41467-019-09234-6
[19] 李恒祺. 鹅去氧胆酸对脂肪肝出血综合征蛋鸡肝脏炎症反应的影响[D]. 沈阳: 沈阳农业大学, 2020.
[20]

BODE N, GREBE A, KERKSIEK A, et al. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice[J]. Biochem Biophys Res Commun,2016,478(1):356-362. doi:  10.1016/j.bbrc.2016.07.047
[21]

ZHOU P, XIE W J, LUO Y, et al. Inhibitory effects of ginsenoside Rb1 on early atherosclerosis in ApoE-/- mice via inhibition of apoptosis and enhancing autophagy[J]. Molecules,2018,23(11):2912. doi:  10.3390/molecules23112912
[22]

LI W F, ZHI W B, ZHAO J M, et al. Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE-/ - mice[J]. Food Funct,2019,10(7):4001-4009. doi:  10.1039/C9FO00396G
[23]

XIANG L, JIANG P, ZHAN C S, et al. The serum metabolomic study of intervention effects of the traditional Chinese medicine Shexiang Baoxin pill and a multi-component medicine polypill in the treatment of myocardial infarction in rats[J]. Mol BioSyst,2012,8(9):2434. doi:  10.1039/c2mb25172h
[24] 王欢, 胡元会, 耿彦婷, 等. 动脉粥样硬化病人动脉硬化程度与血压、血清蛋白的相关性研究[J]. 中西医结合心脑血管病杂志, 2016, 14(12):1321-1324. doi:  10.3969/j.issn.1672-1349.2016.12.004
[25]

TUCKA J, YU H X, GRAY K, et al. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2014,34(11):2421-2428. doi:  10.1161/ATVBAHA.114.304284
[26]

NIGRO J, OSMAN N, DART A M, et al. Insulin resistance and atherosclerosis[J]. Endocr Rev,2006,27(3):242-259. doi:  10.1210/er.2005-0007
[27]

NIE H, ZHENG Y X, LI R S, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis[J]. Nat Med,2013,19(3):322-328. doi:  10.1038/nm.3085
[28]

NAKAHARA H, SONG J, SUGIMOTO M, et al. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis[J]. Arthritis Rheum,2003,48(6):1521-1529. doi:  10.1002/art.11143
[29]

YIN Y Z, YUAN H Y, WANG C G, et al. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation[J]. Mol Endocrinol,2006,20(2):268-278. doi:  10.1210/me.2005-0197
[30]

BAEYENS N, BANDYOPADHYAY C, COON B G, et al. Endothelial fluid shear stress sensing in vascular health and disease[J]. J Clin Invest,2016,126(3):821-828. doi:  10.1172/JCI83083
[31] 丁云录, 李驰坤, 欧喜燕, 等. 散结通脉方对ApoE−/-小鼠动脉粥样硬化主动脉钙库操纵性钙通道信号分子及血清炎症因子的影响[J]. 吉林中医药, 2020, 40(8):1062-1066.
[32]

MA J L, LI H K. The role of gut microbiota in atherosclerosis and hypertension[J]. Front Pharmacol,2018,9:1082. doi:  10.3389/fphar.2018.01082